Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia

Bone Marrow Transplantation volume 45, pages 1508–1513 (2010)Cite this article

Subjects

Abstract

From January 1991 to March 2007, 61 children and adolescent with acquired severe aplastic anemia received BMT in our institutions. We retrospectively compared the outcome of 30 cases of matched-sibling donor BMT (MSD-BMT) and 31 cases of unrelated donor BMT (URD-BMT). We observed one graft failure among MSD-BMT recipients and three graft failures among URD-BMT recipients, respectively. No patients in the MSD-BMT group developed grades II–IV acute GVHD compared with 11 of 30 patients (37%) in the URD-BMT group (P<0.001). One of 30 MSD-BMT recipients (3%) developed chronic GVHD compared with 8 of 30 URD-BMT recipients (27%) (P=0.013). The incidence of EBV and CMV reactivation was 11 of 20 URD-BMT recipients and 23 of 30, respectively. One patient in the URD-BMT group died of a motor accident 5.5 years after BMT. Ten-year OS was 100% in MSD-BMT recipients and 93.8% (95% CI, 81.9–100%) in URD-BMT recipients, respectively (P=0.252). Ten-year failure-free survival was 96.7% (95% CI, 90.2–100%) in the MSD-BMT group and 84.7% (95% CI, 70.2–99.2%) in the URD-BMT group, respectively (P=0.161).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991; 324: 1297–1304.

    Article  CAS  PubMed  Google Scholar 

  2. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995; 85: 1348–1353.

    CAS  PubMed  Google Scholar 

  3. Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996; 94: 65–72.

    Article  CAS  PubMed  Google Scholar 

  4. Deeg HJ, Seidel K, Casper J, Anasetti C, Davies S, Gajeweski JL et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999; 5: 243–252.

    Article  CAS  PubMed  Google Scholar 

  5. Horowitz MM . Current status of allogeneic bone marrow transplantation in acquire aplastic anemia. Semin Hematol 2000; 37: 30–42.

    Article  CAS  PubMed  Google Scholar 

  6. Passweg JR, Perez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 2006; 37: 641–649.

    Article  CAS  PubMed  Google Scholar 

  7. Maury S, Balere-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K et al. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 2007; 92: 589–596.

    Article  PubMed  Google Scholar 

  8. Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 2006; 12: 1277–1284.

    Article  PubMed  Google Scholar 

  9. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP et al. Severe aplastic anemia: a prospective study of the effect of early marrowtransplantation on acute mortality. Blood 1976; 48: 63–70.

    CAS  PubMed  Google Scholar 

  10. Miyamura K, Kojima S, Takeyama K, Matsushita T, Fukuda M, Horibe K et al. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Bone Marrow Transplant 1988; 3: 457–461.

    CAS  PubMed  Google Scholar 

  11. Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N et al. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Bone Marrow Transplant 1997; 19: 1085–1087.

    Article  CAS  PubMed  Google Scholar 

  12. Kojima S, Inaba J, Yoshimi A, Takahashi Y, Watanabe N, Kudo K et al. Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation. Br J Haematol 2001; 114: 706–711.

    Article  CAS  PubMed  Google Scholar 

  13. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119–125.

    CAS  PubMed  Google Scholar 

  14. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplant 1974; 18: 295–304.

    Article  CAS  Google Scholar 

  15. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  PubMed  Google Scholar 

  16. Hoshino Y, Kimua H, Tanaka N, Tsuge I, Kudo K, Horibe K et al. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation. Br J Haematol 2001; 115: 105–111.

    Article  CAS  PubMed  Google Scholar 

  17. Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 2002; 100: 799–805.

    Article  CAS  PubMed  Google Scholar 

  18. Viollier R, Socie G, Tichelli A, Bacigalupo A, Korthof ET, Marsh J et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008; 41: 45–50.

    Article  CAS  PubMed  Google Scholar 

  19. Vassiliou GS, Webb DK, Pamphilon D, Knapper S, Veys PA . Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol 2001; 114: 701–705.

    Article  CAS  PubMed  Google Scholar 

  20. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874–2880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Buyck HC, Ball S, Junagade P, Marsh J, Chakrabarti S . Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia. Bone Marrow Transplant 2009; 43: 813–816.

    Article  CAS  PubMed  Google Scholar 

  22. Armand P, Antin JH . Allogeneic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant 2007; 13: 505–516.

    Article  CAS  PubMed  Google Scholar 

  23. Socié G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E . Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277–279.

    PubMed  Google Scholar 

  24. Kobayashi R, Yabe H, Hara J, Morimoto A, Tsuchida M, Mugishima H et al. Preceding immunosuppressive therapy with antithymocyte globulin and cyclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. Br J Haematol 2006; 135: 693–696.

    Article  CAS  PubMed  Google Scholar 

  25. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, Maury S et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005; 36: 947–950.

    Article  CAS  PubMed  Google Scholar 

  26. Deeg HJ, O’Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485–1491.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Ryu SG et al. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2005; 35: 755–761.

    Article  PubMed  Google Scholar 

  28. Siegal D, Xu W, Sutherland R, Kamel-Reid S, Kuruvilla J, Lipton JH et al. Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplant 2008; 42: 51–56.

    Article  CAS  PubMed  Google Scholar 

  29. Gupta V, Ball SE, Sage D, Ortin M, Freires M, Gordon-Smith EC et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 2005; 35: 467–471.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan

    H Yagasaki, Y Takahashi, A Hama, K Kudo, N Nishio, H Muramatsu, M Tanaka, N Yoshida & S Kojima

  2. Division of Hematology and Oncology, Children's Medical Center, Red Cross Nagoya First Hospital, Nagoya, Japan

    K Matsumoto & K Kato

  3. Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan

    N Watanabe & K Horibe

Authors
  1. H Yagasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Hama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Kudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Nishio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H Muramatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. N Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. K Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. K Horibe
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. S Kojima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Kojima.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yagasaki, H., Takahashi, Y., Hama, A. et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transplant 45, 1508–1513 (2010). https://doi.org/10.1038/bmt.2009.378

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.378

Keywords

This article is cited by

Search

Advanced search

Quick links